Switch to: References

Add citations

You must login to add citations.
  1. Overseeing Innovative Therapy without Mistaking it for Research: A Function-Based Model Based on Old Truths, New Capacities, and Lessons from Stem Cells.Patrick L. Taylor - 2010 - Journal of Law, Medicine and Ethics 38 (2):286-302.
    Innovative therapy is the name we give to novel medical interventions, radically different from the standard of care, provided in order to benefit a patient, rather than to acquire new knowledge. They are paradigmshifting, not incremental, responses to serious patient problems that standard medical care inadequately addresses. Innovative therapies are often devised by clinicians, not basic science researchers; they do not follow the linear model of basic research, to translation, to clinical research, to application. Instead, they come from thinking backwards (...)
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • How Smart are Smart Materials? A Conceptual and Ethical Analysis of Smart Lifelike Materials for the Design of Regenerative Valve Implants.Annelien L. Bredenoord, Carlijn V. C. Bouten, Karin R. Jongsma & Anne-Floor J. de Kanter - 2023 - Science and Engineering Ethics 29 (5):1-18.
    It may soon become possible not just to replace, but to re-grow healthy tissues after injury or disease, because of innovations in the field of Regenerative Medicine. One particularly promising innovation is a regenerative valve implant to treat people with heart valve disease. These implants are fabricated from so-called ‘smart’, ‘lifelike’ materials. Implanted inside a heart, these implants stimulate re-growth of a healthy, living heart valve. While the technological development advances, the ethical implications of this new technology are still unclear (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Embryo Stem Cell Research: Ten Years of Controversy.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):191-203.
    Embryonic stem cell research has been a source of ethical, legal, and social controversy since the first successful culturing of human ESCs in the laboratory in 1998. The controversy has slowed the pace of stem cell science and shaped many aspects of its subsequent development. This paper assesses the main issues that have bedeviled stem cell progress and identifies the ethical fault lines that are likely to continue.The time is appropriate for such an assessment because the field is poised for (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • Unproven stem cell–based interventions and achieving a compromise policy among the multiple stakeholders.Kirstin R. W. Matthews & Ana S. Iltis - 2015 - BMC Medical Ethics 16 (1):1-11.
    BackgroundIn 2004, patient advocate groups were major players in helping pass and implement significant public policy and funding initiatives in stem cells and regenerative medicine. In the following years, advocates were also actively engaged in Washington DC, encouraging policy makers to broaden embryonic stem cell research funding, which was ultimately passed after President Barack Obama came into office. Many advocates did this because they were told stem cell research would lead to cures. After waiting more than 10 years, many of (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Introduction.John A. Robertson - 2010 - Journal of Law, Medicine and Ethics 38 (2):175-190.
    Download  
     
    Export citation  
     
    Bookmark   1 citation